Mitchell Capital Management Co. Buys New Position in The Ensign Group, Inc. $ENSG

Mitchell Capital Management Co. bought a new stake in The Ensign Group, Inc. (NASDAQ:ENSG) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 16,492 shares of the company’s stock, valued at approximately $2,873,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ENSG. Baillie Gifford & Co. raised its position in The Ensign Group by 62.1% in the 4th quarter. Baillie Gifford & Co. now owns 4,569,254 shares of the company’s stock valued at $795,964,000 after buying an additional 1,750,645 shares during the last quarter. Norges Bank acquired a new stake in The Ensign Group in the 4th quarter valued at approximately $134,660,000. Turtle Creek Asset Management Inc. acquired a new stake in The Ensign Group in the 3rd quarter valued at approximately $78,840,000. Victory Capital Management Inc. raised its position in The Ensign Group by 195.4% in the 3rd quarter. Victory Capital Management Inc. now owns 513,328 shares of the company’s stock valued at $88,688,000 after buying an additional 339,534 shares during the last quarter. Finally, Wasatch Advisors LP raised its position in The Ensign Group by 6.0% in the 2nd quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after buying an additional 199,983 shares during the last quarter. Institutional investors and hedge funds own 96.12% of the company’s stock.

The Ensign Group Stock Down 1.9%

NASDAQ:ENSG opened at $167.65 on Friday. The firm has a market capitalization of $9.80 billion, a price-to-earnings ratio of 27.30, a price-to-earnings-growth ratio of 1.65 and a beta of 0.73. The Ensign Group, Inc. has a twelve month low of $134.79 and a twelve month high of $218.00. The stock’s 50 day moving average price is $188.41 and its two-hundred day moving average price is $188.15. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.06.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.06. The firm had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.40 billion. The Ensign Group had a return on equity of 16.78% and a net margin of 6.89%.The business’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.52 EPS. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Equities research analysts expect that The Ensign Group, Inc. will post 6.79 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were given a dividend of $0.065 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The Ensign Group’s payout ratio is 4.23%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ENSG. Truist Financial set a $215.00 target price on The Ensign Group and gave the company a “hold” rating in a research report on Friday, February 6th. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $222.00 price target (up from $206.00) on shares of The Ensign Group in a research report on Monday, February 9th. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of The Ensign Group in a research report on Tuesday, April 21st. Finally, UBS Group set a $230.00 price target on The Ensign Group and gave the stock a “buy” rating in a research report on Friday, February 6th. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $216.75.

Insider Buying and Selling

In related news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction that occurred on Thursday, April 2nd. The stock was sold at an average price of $196.65, for a total transaction of $137,655.00. Following the transaction, the director directly owned 22,152 shares of the company’s stock, valued at approximately $4,356,190.80. The trade was a 3.06% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $199.97, for a total value of $78,388.24. Following the transaction, the director directly owned 9,295 shares in the company, valued at $1,858,721.15. The trade was a 4.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,592 shares of company stock worth $512,364 over the last three months. 4.00% of the stock is owned by insiders.

The Ensign Group Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.